JP2021516966A5 - - Google Patents
Info
- Publication number
- JP2021516966A5 JP2021516966A5 JP2020546981A JP2020546981A JP2021516966A5 JP 2021516966 A5 JP2021516966 A5 JP 2021516966A5 JP 2020546981 A JP2020546981 A JP 2020546981A JP 2020546981 A JP2020546981 A JP 2020546981A JP 2021516966 A5 JP2021516966 A5 JP 2021516966A5
- Authority
- JP
- Japan
- Prior art keywords
- anchor domain
- fusion protein
- binding
- seq
- polypeptide
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862640859P | 2018-03-09 | 2018-03-09 | |
| US62/640,859 | 2018-03-09 | ||
| PCT/US2019/021639 WO2019173829A1 (en) | 2018-03-09 | 2019-03-11 | Delivering biological drugs to tissues |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021516966A JP2021516966A (ja) | 2021-07-15 |
| JPWO2019173829A5 JPWO2019173829A5 (https=) | 2022-03-18 |
| JP2021516966A5 true JP2021516966A5 (https=) | 2022-03-18 |
Family
ID=67846359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020546981A Pending JP2021516966A (ja) | 2018-03-09 | 2019-03-11 | 組織への生物学的薬物の送達 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11529389B2 (https=) |
| EP (1) | EP3762429A4 (https=) |
| JP (1) | JP2021516966A (https=) |
| AU (1) | AU2019231307A1 (https=) |
| WO (1) | WO2019173829A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2695161T3 (es) * | 2011-12-14 | 2019-01-02 | Univ Arkansas | Administración de agentes terapéuticos mediante una proteína de unión a colágeno |
| KR102460040B1 (ko) | 2016-04-27 | 2022-11-01 | 애브비 인코포레이티드 | 항-il-13 항체를 이용한 il-13 활성이 유해한 질환의 치료 방법 |
| US11624060B2 (en) | 2017-02-10 | 2023-04-11 | The Board Of Trustees Of The University Of Arkansas | Collagen-binding agent compositions and methods of using the same |
| US12006345B2 (en) | 2019-02-21 | 2024-06-11 | Xencor, Inc. | Untargeted and targeted IL-10 Fc-fusion proteins |
| LU101758B1 (en) * | 2020-04-28 | 2021-10-28 | Microsoft Technology Licensing Llc | Digital wallet as a relying party in a decentralized network |
| US12403179B2 (en) | 2021-02-18 | 2025-09-02 | The Board Of Trustees Of The University Of Arkansas | Release of growth factors at wound healing stages |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6387663B1 (en) | 1998-07-31 | 2002-05-14 | University Of Southern California | Targeting pharmaceutical agents to injured tissues |
| US20040224010A1 (en) | 2002-11-15 | 2004-11-11 | Optime Therapeutics, Inc. | Ophthalmic liposome compositions and uses thereof |
| US20050027110A1 (en) * | 2003-07-24 | 2005-02-03 | Michael Russell | Drug delivery in the nervous system |
| JP3885077B2 (ja) | 2004-03-26 | 2007-02-21 | 独立行政法人科学技術振興機構 | 三次元ディスプレイ |
| US9187517B2 (en) | 2006-11-13 | 2015-11-17 | The Brigham And Women's Hospital, Inc. | Methods of promoting cardiac repair using growth factors fused to heparin binding sequences |
| US9309313B2 (en) | 2008-01-09 | 2016-04-12 | The Schepens Eye Research Institute, Inc. | Therapeutic compositions for treatment of ocular inflammatory disorders |
| BR112012001977A2 (pt) | 2009-07-29 | 2017-01-31 | Glaxo Group Ltd | domínio variável único de imunoglobulina, polipeptídeo isolado, ligante, proteína de fusão, ácido nucleico isolado, molécula de ácido nucleico isolado, vetor, célula hospedeira, métodos para produzir um polipeptídeo e para tratar e/ou prevenir uma condição, composição farmacêutica, uso de um domínio variável único, e, dispositivo de dispensação pulmonar. |
| WO2012082659A1 (en) * | 2010-12-13 | 2012-06-21 | Cress Jonathan H | Disposable dispenser drop diverter |
| ES2720659T3 (es) | 2011-02-15 | 2019-07-23 | Vaxiion Therapeutics Llc | Composiciones terapéuticas y métodos para la administración dirigida, mediante minicélulas bacterianas, de moléculas bioactivas basadas en moléculas dirigidas que contienen Fc y anticuerpos |
| ES2695161T3 (es) | 2011-12-14 | 2019-01-02 | Univ Arkansas | Administración de agentes terapéuticos mediante una proteína de unión a colágeno |
| US9890378B2 (en) | 2012-05-11 | 2018-02-13 | Merck Sharp & Dohme Corp. | Surface anchored light chain bait antibody display system |
| EP2864360B1 (en) | 2012-06-25 | 2017-09-06 | The Brigham and Women's Hospital, Inc. | Targeted therapeutics |
| WO2014089267A1 (en) | 2012-12-05 | 2014-06-12 | Eleven Biotherapeutics, Inc. | Galectin-3 fusion proteins |
| WO2014096028A1 (en) | 2012-12-19 | 2014-06-26 | Glaxo Group Limited | Guide device for a liquid dispenser |
| HRP20251426T1 (hr) * | 2013-05-06 | 2026-01-02 | Scholar Rock, Inc. | Sastavi i postupci za modulaciju faktora rasta |
| WO2014197485A1 (en) | 2013-06-03 | 2014-12-11 | Ansun Biopharma, Inc. | Anti-viral therapeutic for infection of the eye |
| US9416197B2 (en) | 2013-11-01 | 2016-08-16 | Ibc Pharmaceuticals, Inc. | Bispecific antibodies that neutralize both TNF-α and IL-6: novel therapeutic agent for autoimmune disease |
| CA2968141C (en) * | 2015-01-16 | 2020-08-04 | Hsing-Mao CHU | Molecular constructs with targeting and effector elements |
| US10925972B2 (en) | 2015-05-01 | 2021-02-23 | The Regents Of The University Of California | Glycan-dependent immunotherapeutic molecules |
| EP3516063A4 (en) | 2016-09-20 | 2020-05-13 | University of Pittsburgh- Of the Commonwealth System of Higher Education | USE OF PROTEIN-BASED MEDICINES WITH AN ANCHOR DOMAIN FOR USE ON THE EYE SURFACE |
-
2019
- 2019-03-11 WO PCT/US2019/021639 patent/WO2019173829A1/en not_active Ceased
- 2019-03-11 AU AU2019231307A patent/AU2019231307A1/en not_active Abandoned
- 2019-03-11 JP JP2020546981A patent/JP2021516966A/ja active Pending
- 2019-03-11 EP EP19763843.0A patent/EP3762429A4/en not_active Withdrawn
- 2019-03-11 US US16/979,143 patent/US11529389B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021516966A5 (https=) | ||
| US7582288B2 (en) | Methods of targeting multiple cytokines | |
| EP2016098B1 (en) | Antibody-targeted cytokines for therapy | |
| CN103201284B (zh) | 用于癌症和慢性感染的治疗的具有激动剂活性的衍生自il-2的多肽 | |
| Strober et al. | The interleukins | |
| CN103079586B (zh) | G‑csf二聚体在治疗嗜中性粒细胞减少症中的应用 | |
| JPWO2019157224A5 (https=) | ||
| JP2020501510A5 (https=) | ||
| JP2021533204A5 (https=) | ||
| US10703799B2 (en) | IL-33R and IL-1RAcP fusion proteins | |
| Frieri | Corticosteroid effects on cytokines and chemokines | |
| Kusters et al. | Cytokines and immune responses in murine atherosclerosis | |
| JPWO2019173829A5 (https=) | ||
| TW570801B (en) | Osteoclastgenic inhibitory agent | |
| CN112135623B (zh) | 与疾病的治疗有关的组合物和方法 | |
| Wanebo | Tumor necrosis factors | |
| Kolls et al. | Recombinant cytokines and pulmonary host defense | |
| Bendtzen et al. | Naturally occurring autoantibodies to interleukin-1α, interleukin-6, interleukin-10, and interferon-α | |
| Fujisawa et al. | A synthetic peptide inhibitor for α-chemokines inhibits the tumour growth and pulmonary metastasis of human melanoma cells in nude mice | |
| AU637909B2 (en) | Medical uses of m-csf | |
| US20260028397A1 (en) | Methods of treating ankylosing spondylitis | |
| Saiki et al. | Antimetastatic effect of endogenous tumor necrosis factor induced by the treatment of recombinant interferon γ followed by an analogue (GLA-60) to synthetic lipid A subunit | |
| CN106349393B (zh) | 一种增强抗体药物稳定性的结构 | |
| Lindley | Interleukin-8 | |
| WO2023196916A1 (en) | Methods of treating of hidradenitis suppurativa |